Seeking Alpha

Amarin (AMRN -0.9%) says the European Patent Office has issued an intention to grant letter for...

Amarin (AMRN -0.9%) says the European Patent Office has issued an intention to grant letter for a patent application the company filed to protect the exclusivity of it's drug candidate, AMR101. The patent covers the drugs use in treating Hypertriglyceridemia, an indication that AMRN may seek through the European Medicines Agency. An FDA decision on the drug is due out tomorrow.
Comments (1)
  • brendoo7
    , contributor
    Comments (8) | Send Message
     
    i think its a very good push for company and god news and for investors.
    25 Jul 2012, 01:38 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|